Related references
Note: Only part of the references are listed.Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Deborah P. Merke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency
Nicola Improda et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Shrikant Tamhane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency
Kansuda Ariyawatkul et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency
Adina F. Turcu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
Joseph T. Flynn et al.
PEDIATRICS (2017)
Sex-specific metabolic profiles of androgens and its main binding protein SHBG in a middle aged population without diabetes
Uwe Piontek et al.
SCIENTIFIC REPORTS (2017)
Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
Walter Bonfig et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
Infant BMI or Weight-for-Length and Obesity Risk in Early Childhood
Sani M. Roy et al.
PEDIATRICS (2016)
Metabolic comorbidities in Cushing's syndrome
Francesco Ferrau et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Cardiovascular Abnormalities and Impaired Exercise Performance in Adolescents With Congenital Adrenal Hyperplasia
Alberto M. Marra et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Mimi S. Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study
Henrik Falhammar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Anbezhil Subbarayan et al.
CLINICAL ENDOCRINOLOGY (2014)
Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling
David E. Henley et al.
CLINICAL ENDOCRINOLOGY (2014)
Relationship Between Final Height and Health Outcomes in Adults With Congenital Adrenal Hyperplasia: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE)
T. S. Han et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia
N. H. Amr et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
T. S. Han et al.
CLINICAL ENDOCRINOLOGY (2013)
Obesity and Familial Predisposition Are Significant Determining Factors of an Adverse Metabolic Profile in Young Patients with Congenital Adrenal Hyperplasia
Ricardo P. P. Moreira et al.
HORMONE RESEARCH IN PAEDIATRICS (2013)
Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction
Jennifer Harrington et al.
CLINICAL ENDOCRINOLOGY (2012)
Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
Gabriela P. Finkielstain et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia
R. M. Williams et al.
CLINICAL ENDOCRINOLOGY (2010)
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Robert A. Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients
Wiebke Arlt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
Evanthia Diamanti-Kandarakis et al.
CLINICAL ENDOCRINOLOGY (2008)
Insulin resistance in adolescents
Ann M. Rodden et al.
JOURNAL OF PEDIATRICS (2007)
Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Thomas M. K. Voelkl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome
E Diamanti-Kandarakis et al.
CLINICAL ENDOCRINOLOGY (2005)
Obesity and the metabolic syndrome in children and adolescents
R Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia
NMML Stikkelbroeck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)